DKK2 and neoplasm: To elucidate the mechanism underlying the tumor-derived DKK2-mediated impairment of CD8+ T cell cytotoxicity, we investigated whether DKK2, a canonical Wnt signaling inhibitor (18), induced CD8+ T cell dysfunction by suppressing this pathway.